These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 871143)

  • 21. The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures.
    Martin EW; James KK; Hurtubise PE; Catalano P; Minton JP
    Cancer; 1977 Feb; 39(2):440-6. PubMed ID: 837330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
    Lunde OC; Havig O
    Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoembryonic antigen in cancer of the female reproductive system. Serial plasma values correlated with disease state.
    DiSaia PJ; Morrow CP; Haverback BJ; Dyce BJ
    Cancer; 1977 Jun; 39(6):2365-70. PubMed ID: 194665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Carcinoembryonic antigen (CEA) (author's transl)].
    Staab HJ; Anderer FA; Stumpf E; Fischer R
    Dtsch Med Wochenschr; 1977 Jul; 102(30):1082-6. PubMed ID: 891389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunohistochemical tissue localization of TA-4 and CEA in uterine carcinomas].
    Kimura A; Maruo T; Hoshina M; Mochizuki M
    Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1159-68. PubMed ID: 3323375
    [No Abstract]   [Full Text] [Related]  

  • 26. The prognostic significance of carcinoembryonic antigen determinations in patients with adenocarcinoma of the cervix.
    Kjorstad KE; Orjasaeter H
    Gynecol Oncol; 1984 Nov; 19(3):284-9. PubMed ID: 6500372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of carcinoembryonic antigen in tumor tissue and serum of breast cancer patients.
    Stratil P; Rejthar A; Lang BA; Kocent A; Pacovský Z; Matoska J
    Neoplasma; 1988; 35(1):69-76. PubMed ID: 3352839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphofunctional findings in adenocarcinoma of endometrium.
    Eusebi V; Pelusi G; Bondi A; Morichelli MP; Ceccarelli C; Cavallina R; Mancini AM
    Tumori; 1984 Jun; 70(3):291-5. PubMed ID: 6204431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of tissue carcinoembryonic antigen in patients with colorectal carcinoma.
    Suwanagool P; Fujimori T; Maeda S
    Asian Pac J Allergy Immunol; 1990 Jun; 8(1):33-7. PubMed ID: 2168182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations of plasma CEA levels in gynecologic malignancies: incidence, significance and changes occurring in response to therapy.
    Lecca U; Marcello C; Medda F; Mattana C; Manca P; Fodde M; Caminiti F
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):150-7. PubMed ID: 7341264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.
    Fernandes LC; Kim SB; Saad SS; Matos D
    World J Gastroenterol; 2006 Jun; 12(24):3891-4. PubMed ID: 16804977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinoembryonic antigen in patients with gynecologic malignancies.
    DiSaia PJ; Haverback BJ; Dyce BJ; Morrow CP
    Am J Obstet Gynecol; 1975 Jan; 121(2):159-63. PubMed ID: 163585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differential diagnosis of adenocarcinoma of the uterus and cervix using CEA immunohistochemical staining].
    Wahlström T; Lindgren J; Korhonen M; Seppälä M
    Duodecim; 1980; 96(11):804-7. PubMed ID: 7011782
    [No Abstract]   [Full Text] [Related]  

  • 35. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
    Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
    J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of Plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer.
    Goslin R; O'Brien MJ; Steele G; Mayer R; Wilson R; Corson JM; Zamcheck N
    Am J Med; 1981 Aug; 71(2):246-53. PubMed ID: 6167166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections.
    Goldenberg DM; Sharkey RM; Primus FJ
    J Natl Cancer Inst; 1976 Jul; 57(1):11-22. PubMed ID: 794493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunohistochemical study of difference between cervical and endometrial adenocarcinomas of the uterus--using monoclonal antibodies of CEA and cytokeratin.
    Jinnouchi H
    Fukushima J Med Sci; 1987 Jun; 33(1):29-46. PubMed ID: 2459040
    [No Abstract]   [Full Text] [Related]  

  • 39. Cervical carcinoma antigen, carcinoembryonic antigen (CEA), and nonspecific cross-reacting antigen (NCA) in appraisal of uterine cervix smears.
    Harlozinska A; Kula J; Stepinska B; Jelen M; Richter R; Slesak B
    Am J Clin Pathol; 1985 Mar; 83(3):301-7. PubMed ID: 3883744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
    Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
    Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.